Evaluation of the GORE® ACUSEAL Vascular Graft for Hemodialysis Access
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 138 participants.
Also called NCT01173718
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 138 participants
- Sponsor
- Registry
-
NCT01173718
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01173718. Allocation not applicable; no masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2012-09 (actual). Results posted on 2013-07-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the GORE® ACUSEAL Vascular Graft for Hemodialysis Access
- Acronym
- ACUSEAL
- Condition
- End Stage Renal Disease
- Intervention (Device)
- GORE® ACUSEAL Vascular Graft
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct01173718- Content hash
8b04173d555150b03fbe5c9d2ca802ddb106715e1d99601ee9b56e2b5db773e0